Table 1.
Impact on transplantation | Perfusion | High subzero | Cryobanking |
Expanding the donor pool | x | ||
Ex-vivo functional assessment | x | ||
Ex-vivo immunomodulation | x | ||
Ex-vivo functional enhancement | x | ||
Increasing organ utilization | x | x | x |
Improving transplant outcomes | x | x | x |
Immune tolerance induction | x | x | x |
Disease screening | x | x | x |
Reduced procurement costs | x | x | x |
Reduced postoperative complications | x | x | x |
Increased use of marginal organs | x | x | x |
Improved matching for disadvantaged patients | x | x | x |
Geographic constraints | x | x | x |
Increased hand, limb transplant | x | x | x |
Donor–recipient matching | x | x | x |
Increased organ quality | x | x | x |
Reduced postoperative costs | x | x | x |
Elective scheduling of surgery | x | x | |
On-demand for acute conditions | x | ||
Backup transplant organs | x | ||
Fertility protection for recipients with cancer | x | ||
Off-the-shelf research organs and tissues | x | ||
Future transplant of today's marginal organs | x | ||
Global organ matching | x | ||
Xenotransplantation supply chain | x |
Some impact, including indirect, exists for almost all relationships between the aspects of transplantation shown and each preservation modality; however, the most direct and dramatic impacts are indicated with an ‘x.’